WO2025133909 - TOPICAL COMPOSITION COMPRISING DUTASTERIDE AND MINOXIDIL FOR ALOPECIA
National phase entry is expected:
Publication Number
WO/2025/133909
Publication Date
26.06.2025
International Application No.
PCT/IB2024/062765
International Filing Date
17.12.2024
Title **
[English]
TOPICAL COMPOSITION COMPRISING DUTASTERIDE AND MINOXIDIL FOR ALOPECIA
[French]
COMPOSITION À USAGE TOPIQUE COMPRENANT DU DUTASTÉRIDE ET DU MINOXIDIL CONTRE L'ALOPÉCIE
Applicants **
GLENMARK SPECIALTY S.A.
Inventors
OTAVKAR, Roopali
ABRAHAM, Jaya
BANGAR, Ganesh
DHUPPAD, Ulhas
KULKARNI, Abhay
GANDHI, Maulik
UDUPA, Venkatesh
PAWAR, Pramod
CHOPADE, Atul
Priority Data
202321086964
19.12.2023
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2340 | |
| EPO | Filing, Examination, Granting | 10528 | |
| Japan | Filing, Examination, Granting | 2247 | |
| South Korea | Filing, Examination, Granting | 2259 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
22,114
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The invention relates to a composition comprising minoxidil and dutasteride with one or more pharmaceutically acceptable excipient. Further the invention relates to process of preparing such composition. Further the invention relates to topical application of the composition for preventing hair loss and/or stimulating hair growth. Further invention relates to achieving acceptable pharmacokinetic parameters to give beneficial therapeutic effect with minimal side effects.[French]
L'invention concerne une composition comprenant du minoxidil et du dutastéride avec un ou plusieurs excipients pharmaceutiquement acceptables. L'invention concerne en outre un procédé de préparation d'une telle composition. L'invention concerne en outre l'application topique de la composition pour prévenir la chute des cheveux et/ou stimuler la pousse des cheveux. L'invention concerne en outre l'obtention de paramètres pharmacocinétiques acceptables pour fournir un effet thérapeutique bénéfique avec des effets secondaires réduits au minimum.